An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

BACKGROUND: In ovarian cancer, the reported rate of EGFR expression varies between 4-70% depending on assessment method and data on patient outcome are conflicting. Methods: In this study we investigated EGFR expression and its prognostic value in a cohort of 121 invasive ovarian carcinomas, using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Noske, Aurelia, Schwabe, Michael, Weichert, Wilko, Darb-Esfahani, Silvia, Buckendahl, Ann-Christin, Sehouli, Jalid, Braicu, Elena I, Budczies, Jan, Dietel, Manfred, Denkert, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149030/
https://www.ncbi.nlm.nih.gov/pubmed/21756326
http://dx.doi.org/10.1186/1471-2407-11-294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149030/
https://www.ncbi.nlm.nih.gov/pubmed/21756326
http://dx.doi.org/10.1186/1471-2407-11-294

Ejemplares similares